Nikki
Reeves

Nikki counsels pharma and device companies on FDA Form 483s, Warning Letters, product recalls, import detentions, clinical holds, and other FDA compliance and enforcement matters.  She conducts risk assessments and internal investigations into noncompliance and presents findings to company executives and board members.  She handles company responses to government inquiries and related communications to the government for her clients.  She has established robust compliance programs and policies for numerous life sciences companies. Nikki has also served as an interim General Counsel and as a Chief Compliance Officer for her life sciences clients.

Nikki leads two pharma and device industry coalitions on transparency and disclosure laws.   The  Ad Hoc Sunshine and State Law Compliance Group is a coalition she advises on federal Sunshine Act and state transparency/disclosure and gift ban laws.  The International Marketing and Disclosure Compliance Group is a separate coalition of companies she advises on the growing area of transparency and disclosure laws and industry codes of conduct in the EU, Australia, Japan, and numerous other countries and regions.

Nikki is a frequent speaker and author on FDA advertising/promotion and transparency law matters.  She currently serves on the Advisory Board for FDAnews.  She was formerly on the Food and Drug Law Institute (FDLI) Editorial Advisory Board for the FDLI Food & Drug Law Journal and a member of the FDLI Medical Device Committee.  Nikki has also served on the Leadership Advisory Board for the National Women’s Law Center and on the Special Gifts Committee for the Arlington Free Clinic. 

Nikki was elected by her partners to serve a three-year term on the firm’s Policy Committee in 2017.  Nikki previously served a three-year term as a member of the firm’s Lateral Partner Committee and a three-year term as a member of the firm's Partners Committee, and served a two-year term as the Hiring Partner for the Washington, D.C. office.